Enovix Corporation (NASDAQ:ENVX – Get Free Report) shares rose 5.3% during trading on Tuesday. The company traded as high as $2.68 and last traded at $2.6950. Approximately 871,017 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 6,652,274 shares. The stock had previously closed at $2.56.
Wall Street Analysts Forecast Growth
ENVX has been the subject of several research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $25.00 price target on shares of Enovix in a research note on Thursday, August 13th. Canaccord Genuity Group reduced their price objective on Enovix from $15.00 to $10.00 and set a “buy” rating on the stock in a research report on Friday, August 14th. William Blair cut Enovix from an “outperform” rating to a “market perform” rating in a report on Monday, August 17th. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Finally, Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, September 12th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $11.77.
View Our Latest Research Report on ENVX
Enovix Stock Performance
Enovix (NASDAQ:ENVX – Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.02. The business had revenue of $9.02 million for the quarter, compared to analyst estimates of $8.43 million. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%.Enovix’s revenue for the quarter was up 20.8% compared to the same quarter last year. During the same period last year, the company earned ($0.13) EPS. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. On average, sell-side analysts anticipate that Enovix Corporation will post -0.8 earnings per share for the current year.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in Enovix during the 2nd quarter valued at $100,054,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Enovix in the 2nd quarter worth about $8,689,000. Bank of America Corp DE purchased a new stake in shares of Enovix in the 2nd quarter worth about $8,356,000. CenterBook Partners LP boosted its stake in shares of Enovix by 66.1% during the 4th quarter. CenterBook Partners LP now owns 1,757,382 shares of the company’s stock valued at $12,846,000 after purchasing an additional 699,519 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new stake in shares of Enovix during the 2nd quarter valued at about $3,551,000. Institutional investors own 50.92% of the company’s stock.
Enovix Company Profile
Enovix Corporation (NASDAQ: ENVX) is a battery technology company developing lithium-ion batteries with silicon-anode materials and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while maintaining safety and durability for applications that require compact, high-performance energy storage.
The company’s battery platform incorporates a silicon anode, a stainless-steel constraint system and its BrakeFlow technology, which is designed to help prevent thermal runaway from spreading within a battery pack.
See Also
- Five stocks we like better than Enovix
- Rocket Lab Bounces Off Its Lows—What’s Behind the Move?
- NVIDIA Just Turned AI Safety Into a Spending Story and These 3 Stocks Benefit
- Why SpaceX Investors Should Look Past Starship’s Fiery Splashdown
- Meta’s Muse Is Taking Aim at E-Commerce, But Amazon Isn’t Playing Along
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
